Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.47 USD | -5.44% | +0.54% | +64.18% |
May. 21 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
May. 21 | Investors Tread Cautiously as Nvidia Earnings Loom, Driving Muted Premarket Action for US Equity Futures | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 504M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -138M | EV / Sales 2024 * | - |
Net cash position 2024 * | 185M | Net cash position 2025 * | 59.3M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.05
x | P/E ratio 2025 * |
-3.67
x | Employees | 42 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.55% |
Latest transcript on Larimar Therapeutics, Inc.
1 day | -7.53% | ||
1 week | -0.81% | ||
Current month | +6.97% | ||
1 month | +14.09% | ||
3 months | -39.19% | ||
6 months | +110.57% | ||
Current year | +61.98% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | - | |
Michael Celano
DFI | Director of Finance/CFO | 65 | 20-05-27 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20-05-27 |
Frank Thomas
BRD | Director/Board Member | 54 | 20-05-27 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 23-10-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 7.47 | -5.44% | 462 129 |
24-05-22 | 7.9 | +0.13% | 1,555,368 |
24-05-21 | 7.89 | +8.53% | 3,012,463 |
24-05-20 | 7.27 | -1.49% | 773,420 |
24-05-17 | 7.38 | -0.67% | 284,266 |
Delayed Quote Nasdaq, May 23, 2024 at 02:22 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.98% | 504M | |
+10.52% | 115B | |
+12.15% | 106B | |
-4.81% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.64% | 17.56B | |
-40.50% | 17.32B | |
+6.02% | 14.03B | |
+30.56% | 12.13B |
- Stock Market
- Equities
- LRMR Stock